Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.
Also called NCT07397351
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Phase 2
- Enrolled
- 180 participants
- Sponsor
- Research Institute of Geroprotective Technologies
- Registry
-
NCT07397351
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Recruiting
Technical summary
Registry record NCT07397351. Randomized; no masking; primary purpose supportive care. Start 2026-03-05 (actual); primary completion 2026-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Aroxxen
- Lead sponsor
- Research Institute of Geroprotective Technologies
Record details
- Record id
cardio:ct-nct07397351- Content hash
10f8cbba998fade52fb034a7d3620d8c6b88fc9cff3662982e3fc26f493a4cfd